Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma

Journal of Neuropathology & Experimental Neurology(2023)10.1093/jnen/nlac121Source: DataRank Database

Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma is a research paper published in Journal of Neuropathology & Experimental Neurology (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.14)OA: bronzeTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Saman Ahmadian ORCID,Sushma Bharadwaj ORCID,Lehi Acosta-Alvarez ORCID,Zachary Threlkeld ORCID,Matthew J. Frank ORCID

Live enrichment

PubMed:36592076 PMC:PMC10655196 OpenAlex:https://openalex.org/W4313423890

NINDS NIH HHS

Grant: R25 NS065741

NIH

FWCI

1.14

Citation Percentile

0.8%

Citation Trend

2024

2025

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://academic.oup.com/jnen/article-pdf/82/2/160/52172863/nlac121.pdf

publisherhttps://academic.oup.com/jnen/article-pdf/82/2/160/52172863/nlac121.pdf

journalhttps://doi.org/10.1093/jnen/nlac121

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36592076

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10655196

Fields of Study

CAR-T cell therapy researchNanowire Synthesis and ApplicationsIntegrated Circuits and Semiconductor Failure AnalysisAnimalsLymphoma, Mantle-CellImmunotherapy, AdoptiveReceptors, Chimeric AntigenNeurotoxicity SyndromesLeukoencephalopathy, Progressive MultifocalAdaptor Proteins, Signal Transducing

MeSH Terms

Receptors, Chimeric AntigenAnimalsLeukoencephalopathy, Progressive MultifocalImmunotherapy, AdoptiveNeurotoxicity SyndromesLymphoma, Mantle-CellAdaptor Proteins, Signal Transducing

Keywords

NeurotoxicityMedicineImmunologyImmune systemBiologyPathologyInternal medicineToxicityImmunotherapyMantle Cell LymphomaOligodendrocyte Progenitor CellImmune Effector Cell-associated Neurotoxicity Syndrome (Icans)Chimeric Antigen Receptor T-cell (Car T) TherapyMultifocal Demyelinating Leukoencephalopathy

Sustainable Development Goals

SDG 0: Good health and well-being